Announced Fri, 29 May · 19:29 IST
We attach herewith Statement of Deviation/Variation under Regulation 32 (1) of SEBI (LODR) Regulations, 2015
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-9.7%1-day move
₹88.01
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-9.7-14.2-18.4-14.8-14.8-16.5—-18.1——
Up moveDown movePending
AI summary
Raaj Medisafe India Ltd filed its quarterly statement under SEBI Regulation 32 confirming that funds of Rs. 18.01 crore raised via a Preferential Issue (completed on March 26, 2026) are being utilised as per the originally stated objects. The Audit Committee reviewed the utilisation statement on May 29, 2026, and found no deviation or variation in how the funds are being used. No comments were raised by either the Audit Committee or the auditors.
Likely market impact
No negative signal — the company is deploying the raised capital as intended with no deviations reported, which is a standard compliance update with neutral market impact.